A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer. Furrer MA, Papa N, Luetolf S, Roth B, et al. BJU Int 2021 Aug 21. doi: 10.1111/bju.15579.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Furrer MA, Papa N, Luetolf S, Roth B, et al. A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer. BJU Int 2021 Aug 21. doi: 10.1111/bju.15579.
PMID: 34418255